These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 20065511)
1. The effect of nebivolol on atherogenesis in apoE-knockout mice. Kus K; Gajda M; Pyka-Fosciak G; Toton-Zuranska J; Pawlowska M; Suski M; Niepsuj A; Nowak B; Wolkow P; Olszanecki R; Jawien J; Korbut R J Physiol Pharmacol; 2009 Dec; 60(4):163-5. PubMed ID: 20065511 [TBL] [Abstract][Full Text] [Related]
2. Significant deterioration of anti-atherogenic efficacy of nebivolol in a double (apolipoprotein E and endothelial nitric oxide synthase) knockout mouse model of atherosclerosis in comparison to single (apolipoprotein E) knockout model. Kus K; Wisniewska A; Toton-Zuranska J; Olszanecki R; Jawien J; Korbut R J Physiol Pharmacol; 2014 Dec; 65(6):877-81. PubMed ID: 25554992 [TBL] [Abstract][Full Text] [Related]
3. The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. Jawien J; Gajda M; Wołkow P; Zurańska J; Olszanecki R; Korbut R J Physiol Pharmacol; 2008 Sep; 59(3):633-9. PubMed ID: 18953103 [TBL] [Abstract][Full Text] [Related]
4. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice. Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472 [TBL] [Abstract][Full Text] [Related]
6. The influence of angiotensin-(1-7) peptidomimetic (AVE 0991) and nebivolol on angiotensin I metabolism in aorta of apoE-knockout mice. Olszanecki R; Suski M; Gebska A; Toton-Zuranska J; Kus K; Madej J; Bujak-Gizycka B; Jawien J; Korbut R J Physiol Pharmacol; 2013 Jun; 64(3):317-20. PubMed ID: 23959728 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits. de Nigris F; Mancini FP; Balestrieri ML; Byrns R; Fiorito C; Williams-Ignarro S; Palagiano A; Crimi E; Ignarro LJ; Napoli C Nitric Oxide; 2008 Aug; 19(1):57-63. PubMed ID: 18435936 [TBL] [Abstract][Full Text] [Related]
8. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart. Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564 [TBL] [Abstract][Full Text] [Related]
9. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. Olszanecki R; Jawień J; Gajda M; Mateuszuk L; Gebska A; Korabiowska M; Chłopicki S; Korbut R J Physiol Pharmacol; 2005 Dec; 56(4):627-35. PubMed ID: 16391419 [TBL] [Abstract][Full Text] [Related]
10. [Nebivolol: a beta blocker with vasodilator properties]. Waeber B Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847 [TBL] [Abstract][Full Text] [Related]
11. [Role of the L-arginine/nitric oxide system in the action of nebivolol]. Brodde OE; Philipp T Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442 [TBL] [Abstract][Full Text] [Related]
12. AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice. Toton-Zuranska J; Gajda M; Pyka-Fosciak G; Kus K; Pawlowska M; Niepsuj A; Wolkow P; Olszanecki R; Jawien J; Korbut R J Physiol Pharmacol; 2010 Apr; 61(2):181-3. PubMed ID: 20436218 [TBL] [Abstract][Full Text] [Related]
14. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Gupta S; Wright HM Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089 [TBL] [Abstract][Full Text] [Related]
15. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study]. von Fallois J; Faülhaber HD Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490 [TBL] [Abstract][Full Text] [Related]